The oral microbiota in colorectal cancer is distinctive and predictive
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Empty strings are not accepted.
Subjects
- Location of subjects
- Ireland
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Oral cavity Bucca,Buccal cavity,Cavity of mouth,Oral cavity,oral cavity
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Colorectal carcinoma
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Healthy Controls
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Individuals with CRC
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Individuals diagnosed with CRC
- Group 0 sample size Number of subjects in the control (unexposed) group
- 103
- Group 1 sample size Number of subjects in the case (exposed) group
- 99
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 1 month
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- centered log-ratio
- Statistical test
- ANCOM
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
Signature 1
Source: Figure 5(B)
Description: Scatterplot of the colonic prevalence of bacterial OTUs associated with oral pathogen and biofilm CAGs.
Abundance in Group 1: increased abundance in Individuals with CRC
NCBI | Quality Control | Links |
---|---|---|
Dialister | ||
Fusobacterium | ||
Gemella | ||
Parvimonas | ||
Peptostreptococcus | ||
Solobacterium | ||
Streptococcus |
Experiment 2
Empty strings are not accepted.
Subjects
Lab analysis
Statistical Analysis
Signature 1
Source: supplementary table 2
Description: Differentially abundant taxa in the oral microbiome between colorectal cancer patients and healthy controls by ANCOM
Abundance in Group 1: increased abundance in Individuals with CRC
NCBI | Quality Control | Links |
---|---|---|
Haemophilus | ||
Parvimonas | ||
Prevotella | ||
Alloprevotella | ||
Lachnoanaerobaculum | ||
Neisseria | ||
Streptococcus |
Experiment 3
Empty strings are not accepted.
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Individuals with polyps
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Individuals diagnosed with polyps
- Group 1 sample size Number of subjects in the case (exposed) group
- 32
Lab analysis
Statistical Analysis
Signature 1
Source: supplementary table 2
Description: Differentially abundant taxa in the oral microbiome between colorectal cancer patients and healthy controls by ANCOM
Abundance in Group 1: increased abundance in Individuals with polyps
NCBI | Quality Control | Links |
---|---|---|
Parvimonas | ||
Streptococcus | ||
Leptotrichia |